Sort
64,565 grants matching “drug discovery”
Drug discovery of COMT inhibitors to treat cognitive deficits in schizophrenia
$809,271James Barrow · Lieber Institute, Inc. · R01 · FY2016 · MH
Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer
$809,248Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer
$809,234Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
Development of the UValidate platform for the profiling of topically applied chemical agents.
$809,224Peter Sykora · Amelia Technologies, Llc · R42 · FY2022 · ES
The Role of Biofilms in the Pathogenesis of Otorrhea
$809,222Garth D. Ehrlich · Allegheny-Singer Research Institute · R01 · FY2007 · DC
Relaxivity Contrast Imaging as Biomarker of Muscle Degeneration in ALS
$809,219Christopher Chad Quarles · St. Joseph'S Hospital And Medical Center · R61 · FY2022 · NS
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease
$809,200Li Shen · University Of Pennsylvania · R01 · FY2021 · AG
Expansion of an efficient drug repurposing platform for rare genetic diseases.
$809,130Christopher Gibson · Recursion Pharmaceuticals, Llc · R44 · FY2015 · TR
Open-Source Toolkit for Knowledge-Based Querying of Time-Oriented Data
$809,109Amarendra K. Das · Stanford University · R01 · FY2010 · LM
Ligand discovery for delineating cholesterol homeostasis in the brain
$808,990Steven H Liang · Massachusetts General Hospital · R01 · FY2021 · AG
Calcium Pump Activators for Heart Failure Therapy
$808,914David Dale Thomas · University Of Minnesota · R01 · FY2015 · HL
The regulation of synaptic transmission and neural circuit function
$808,811Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Molecular Chemiluminescence Probes for Imaging of Amyloid beta in Animal Models
$808,786Chongzhao Ran · Massachusetts General Hospital · R01 · FY2025 · AG
Lead optimization of novel ML-IAP antagonists to treat lung cancer
$808,701Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · CA
Targeting the Genus Leishmania with Small Molecules
$808,549Scott Edward Schaus · Boston University (Charles River Campus) · R01 · FY2021 · AI
MSHS Translational Science Hub
$808,544Alan J Moskowitz · Icahn School Of Medicine At Mount Sinai · KL2 · FY2016 · TR
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER
$808,473Haian Fu · Emory University · U01 · FY2013 · CA
High Throughput Protein-Protein Interaction Interrogation in Cancer
$808,473Haian Fu · Emory University · U01 · FY2013 · CA
Structural bioinformatics software for epitope selection and antibody engineering
$808,267Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2015 · GM
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$808,122Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Mechanisms of FGF Receptor Regulation and Signaling
$807,903Moosa Mohammadi · New York University School Of Medicine · R01 · FY2013 · DE
Pediatric toxicity and efficacy in long-term systemic treatment with anti-sense
$807,794John N Van Den Anker · Children'S Research Institute · U54 · FY2015 · HD
Pediatric toxicity and efficacy in long-term systemic treatment with anti-sense
$807,792John N Van Den Anker · Children'S Research Institute · U54 · FY2012 · HD
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
$807,677Jeffrey Aube · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
High Content Screening for Bifunctional Chimera Biologics
$807,664Liz Valente · Heligenics Inc · R44 · FY2025 · AI